Douglas Liu - Oct 2, 2021 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Chief Operating Officer
Signature
/s/ Karen E. Flick, Attorney-in-Fact for Douglas Liu
Stock symbol
TLIS
Transactions as of
Oct 2, 2021
Transactions value $
$0
Form type
4
Date filed
10/5/2021, 04:49 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Award +200K +63.56% 515K Oct 2, 2021 Common Stock 200K $6.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
F2 Price not required on initial report of stock option granted.